Literature DB >> 21058102

Editorial: Adaptive designs: appealing in development of therapeutics, and where do controversies lie?

Sue-Jane Wang.   

Abstract

Mesh：

Year:  2010        PMID： 21058102     DOI： 10.1080/10543406.2010.514461

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN： 1054-3406            Impact factor:   1.051


× No keyword cloud information.
  3 in total

1.  Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paper.

Authors:  Thomas J Herzog; Deborah K Armstrong; Mark F Brady; Robert L Coleman; Mark H Einstein; Bradley J Monk; Robert S Mannel; J Tate Thigpen; Sharee A Umpierre; Jeannine A Villella; Ronald D Alvarez
Journal:  Gynecol Oncol       Date:  2013-11-15       Impact factor: 5.482

Review 2.  Efficiency perspectives on adaptive designs in stroke clinical trials.

Authors:  Ken Cheung; Petra Kaufmann
Journal:  Stroke       Date:  2011-09-01       Impact factor: 7.914

3.  Adaptive design of confirmatory trials: Advances and challenges.

Authors:  Tze Leung Lai; Philip W Lavori; Ka Wai Tsang
Journal:  Contemp Clin Trials       Date:  2015-06-14       Impact factor: 2.226
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.